aluates Reports

$ 0.0

Automative

Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-13I9059

Global Hyperimmune Globulins Market Outlook 2022

BUY CHAPTERS

Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-13I9059

Report

August 2025

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Behring

Grifols S A

Biotest

Kedrion S p A

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai Raas

Sichuan Yuanda Shuyang

ADMA Biologics

Hyperimmune Globulins- Market Size

The global market for Hyperimmune Globulins was estimated to be worth US$ 1936 million in 2024 and is forecast to a readjusted size of US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

Hyperimmune Globulins- Market

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%. Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent. In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

The hyperimmune globulin market is primarily driven by the increasing prevalence of infectious diseases and the rising demand for immunoglobulin therapies. These therapies are crucial in treating immunodeficiency disorders and providing passive immunity against various pathogens, which fuels market growth. Additionally, advancements in plasma-derived therapies and increasing government initiatives for immunization programs contribute to market expansion.

However, the market faces significant challenges, such as the high cost of treatment and limited availability of plasma, which is a critical raw material for hyperimmune globulin production. Moreover, stringent regulatory requirements for product approval and potential side effects associated with immunoglobulin therapies can hinder market growth.

This report aims to provide a comprehensive presentation of the global market for Hyperimmune Globulins, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hyperimmune Globulins by region & country, by Type, and by Application.

The Hyperimmune Globulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulins.

Market Segmentation

Scope of Hyperimmune Globulins- Market Report

Report Metric	Details
Report Name	Hyperimmune Globulins- Market
Forecasted market size in 2031	US$ 3089 million
CAGR	7.0%
Forecasted years	2025 - 2031
Segment by Type	Hepatitis B Immunoglobulins Rabies Immunoglobulins Tetanus Immunoglobulins Rho(D) Immunoglobulins Herpes Zoster Immune Globulin Other
Segment by Application	Government Institutions Private Sector Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hyperimmune Globulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hyperimmune Globulins in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hyperimmune Globulins- Market size in 2031?

Ans: The Hyperimmune Globulins- Market size in 2031 will be US$ 3089 million.

What is the market share of major companies in Hyperimmune Globulins- Market?

Ans: Global top two manufacturers hold a share over 50%.

Who are the main players in the Hyperimmune Globulins- Market report?

Ans: The main players in the Hyperimmune Globulins- Market are CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics

What are the Application segmentation covered in the Hyperimmune Globulins- Market report?

Ans: The Applications covered in the Hyperimmune Globulins- Market report are Government Institutions, Private Sector, Other

What are the Type segmentation covered in the Hyperimmune Globulins- Market report?

Ans: The Types covered in the Hyperimmune Globulins- Market report are Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins, Herpes Zoster Immune Globulin, Other

1 Market Overview

1.1 Hyperimmune Globulins Product Introduction

1.2 Global Hyperimmune Globulins Market Size Forecast

1.2.1 Global Hyperimmune Globulins Sales Value (2020-2031)

1.2.2 Global Hyperimmune Globulins Sales Volume (2020-2031)

1.2.3 Global Hyperimmune Globulins Sales Price (2020-2031)

1.3 Hyperimmune Globulins Market Trends & Drivers

1.3.1 Hyperimmune Globulins Industry Trends

1.3.2 Hyperimmune Globulins Market Drivers & Opportunity

1.3.3 Hyperimmune Globulins Market Challenges

1.3.4 Hyperimmune Globulins Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hyperimmune Globulins Players Revenue Ranking (2024)

2.2 Global Hyperimmune Globulins Revenue by Company (2020-2025)

2.3 Global Hyperimmune Globulins Players Sales Volume Ranking (2024)

2.4 Global Hyperimmune Globulins Sales Volume by Company Players (2020-2025)

2.5 Global Hyperimmune Globulins Average Price by Company (2020-2025)

2.6 Key Manufacturers Hyperimmune Globulins Manufacturing Base and Headquarters

2.7 Key Manufacturers Hyperimmune Globulins Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hyperimmune Globulins

2.9 Hyperimmune Globulins Market Competitive Analysis

2.9.1 Hyperimmune Globulins Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Hyperimmune Globulins Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hepatitis B Immunoglobulins

3.1.2 Rabies Immunoglobulins

3.1.3 Tetanus Immunoglobulins

3.1.4 Rho(D) Immunoglobulins

3.1.5 Herpes Zoster Immune Globulin

3.1.6 Other

3.2 Global Hyperimmune Globulins Sales Value by Type

3.2.1 Global Hyperimmune Globulins Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Hyperimmune Globulins Sales Value, by Type (2020-2031)

3.2.3 Global Hyperimmune Globulins Sales Value, by Type (%) (2020-2031)

3.3 Global Hyperimmune Globulins Sales Volume by Type

3.3.1 Global Hyperimmune Globulins Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Hyperimmune Globulins Sales Volume, by Type (2020-2031)

3.3.3 Global Hyperimmune Globulins Sales Volume, by Type (%) (2020-2031)

3.4 Global Hyperimmune Globulins Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Government Institutions

4.1.2 Private Sector

4.1.3 Other

4.2 Global Hyperimmune Globulins Sales Value by Application

4.2.1 Global Hyperimmune Globulins Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Hyperimmune Globulins Sales Value, by Application (2020-2031)

4.2.3 Global Hyperimmune Globulins Sales Value, by Application (%) (2020-2031)

4.3 Global Hyperimmune Globulins Sales Volume by Application

4.3.1 Global Hyperimmune Globulins Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Hyperimmune Globulins Sales Volume, by Application (2020-2031)

4.3.3 Global Hyperimmune Globulins Sales Volume, by Application (%) (2020-2031)

4.4 Global Hyperimmune Globulins Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Hyperimmune Globulins Sales Value by Region

5.1.1 Global Hyperimmune Globulins Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Hyperimmune Globulins Sales Value by Region (2020-2025)

5.1.3 Global Hyperimmune Globulins Sales Value by Region (2026-2031)

5.1.4 Global Hyperimmune Globulins Sales Value by Region (%), (2020-2031)

5.2 Global Hyperimmune Globulins Sales Volume by Region

5.2.1 Global Hyperimmune Globulins Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Hyperimmune Globulins Sales Volume by Region (2020-2025)

5.2.3 Global Hyperimmune Globulins Sales Volume by Region (2026-2031)

5.2.4 Global Hyperimmune Globulins Sales Volume by Region (%), (2020-2031)

5.3 Global Hyperimmune Globulins Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Hyperimmune Globulins Sales Value, 2020-2031

5.4.2 North America Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Hyperimmune Globulins Sales Value, 2020-2031

5.5.2 Europe Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Hyperimmune Globulins Sales Value, 2020-2031

5.6.2 Asia Pacific Hyperimmune Globulins Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Hyperimmune Globulins Sales Value, 2020-2031

5.7.2 South America Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hyperimmune Globulins Sales Value, 2020-2031

5.8.2 Middle East & Africa Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hyperimmune Globulins Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Hyperimmune Globulins Sales Value

6.2.1 Key Countries/Regions Hyperimmune Globulins Sales Value, 2020-2031

6.2.2 Key Countries/Regions Hyperimmune Globulins Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Hyperimmune Globulins Sales Value, 2020-2031

6.3.2 United States Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Hyperimmune Globulins Sales Value, 2020-2031

6.4.2 Europe Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Hyperimmune Globulins Sales Value, 2020-2031

6.5.2 China Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.5.3 China Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Hyperimmune Globulins Sales Value, 2020-2031

6.6.2 Japan Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Hyperimmune Globulins Sales Value, 2020-2031

6.7.2 South Korea Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Hyperimmune Globulins Sales Value, 2020-2031

6.8.2 Southeast Asia Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Hyperimmune Globulins Sales Value, 2020-2031

6.9.2 India Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

6.9.3 India Hyperimmune Globulins Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 CSL Behring

7.1.1 CSL Behring Company Information

7.1.2 CSL Behring Introduction and Business Overview

7.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 CSL Behring Hyperimmune Globulins Product Offerings

7.1.5 CSL Behring Recent Development

7.2 Grifols

7.2.1 Grifols Company Information

7.2.2 Grifols Introduction and Business Overview

7.2.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Grifols Hyperimmune Globulins Product Offerings

7.2.5 Grifols Recent Development

7.3 Biotest

7.3.1 Biotest Company Information

7.3.2 Biotest Introduction and Business Overview

7.3.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Biotest Hyperimmune Globulins Product Offerings

7.3.5 Biotest Recent Development

7.4 Kedrion

7.4.1 Kedrion Company Information

7.4.2 Kedrion Introduction and Business Overview

7.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Kedrion Hyperimmune Globulins Product Offerings

7.4.5 Kedrion Recent Development

7.5 CBPO

7.5.1 CBPO Company Information

7.5.2 CBPO Introduction and Business Overview

7.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 CBPO Hyperimmune Globulins Product Offerings

7.5.5 CBPO Recent Development

7.6 Emergent (Cangene)

7.6.1 Emergent (Cangene) Company Information

7.6.2 Emergent (Cangene) Introduction and Business Overview

7.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Emergent (Cangene) Hyperimmune Globulins Product Offerings

7.6.5 Emergent (Cangene) Recent Development

7.7 Kamada

7.7.1 Kamada Company Information

7.7.2 Kamada Introduction and Business Overview

7.7.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Kamada Hyperimmune Globulins Product Offerings

7.7.5 Kamada Recent Development

7.8 CNBG

7.8.1 CNBG Company Information

7.8.2 CNBG Introduction and Business Overview

7.8.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 CNBG Hyperimmune Globulins Product Offerings

7.8.5 CNBG Recent Development

7.9 Hualan Bio

7.9.1 Hualan Bio Company Information

7.9.2 Hualan Bio Introduction and Business Overview

7.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Hualan Bio Hyperimmune Globulins Product Offerings

7.9.5 Hualan Bio Recent Development

7.10 Shanghai RAAS

7.10.1 Shanghai RAAS Company Information

7.10.2 Shanghai RAAS Introduction and Business Overview

7.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Shanghai RAAS Hyperimmune Globulins Product Offerings

7.10.5 Shanghai RAAS Recent Development

7.11 Sichuan Yuanda Shuyang

7.11.1 Sichuan Yuanda Shuyang Company Information

7.11.2 Sichuan Yuanda Shuyang Introduction and Business Overview

7.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Offerings

7.11.5 Sichuan Yuanda Shuyang Recent Development

7.12 ADMA Biologics

7.12.1 ADMA Biologics Company Information

7.12.2 ADMA Biologics Introduction and Business Overview

7.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 ADMA Biologics Hyperimmune Globulins Product Offerings

7.12.5 ADMA Biologics Recent Development

8 Industry Chain Analysis

8.1 Hyperimmune Globulins Industrial Chain

8.2 Hyperimmune Globulins Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hyperimmune Globulins Sales Model

8.5.2 Sales Channel

8.5.3 Hyperimmune Globulins Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

CSL Behring

Grifols S A

Biotest

Kedrion S p A

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai Raas

Sichuan Yuanda Shuyang

ADMA Biologics

List of Tables

Table 1. Hyperimmune Globulins Market Trends

Table 2. Hyperimmune Globulins Market Drivers & Opportunity

Table 3. Hyperimmune Globulins Market Challenges

Table 4. Hyperimmune Globulins Market Restraints

Table 5. Global Hyperimmune Globulins Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Hyperimmune Globulins Revenue Market Share by Company (2020-2025)

Table 7. Global Hyperimmune Globulins Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Hyperimmune Globulins Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Hyperimmune Globulins Price by Company (2020-2025) & (USD/Unit)

Table 10. Key Manufacturers Hyperimmune Globulins Manufacturing Base and Headquarters

Table 11. Key Manufacturers Hyperimmune Globulins Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hyperimmune Globulins

Table 13. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hyperimmune Globulins Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Hyperimmune Globulins Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Hyperimmune Globulins Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Hyperimmune Globulins Sales Market Share in Value by Type (2020-2025)

Table 20. Global Hyperimmune Globulins Sales Market Share in Value by Type (2026-2031)

Table 21. Global Hyperimmune Globulins Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Hyperimmune Globulins Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Hyperimmune Globulins Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Hyperimmune Globulins Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Hyperimmune Globulins Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Hyperimmune Globulins Price by Type (2020-2025) & (USD/Unit)

Table 27. Global Hyperimmune Globulins Price by Type (2026-2031) & (USD/Unit)

Table 28. Global Hyperimmune Globulins Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Hyperimmune Globulins Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Hyperimmune Globulins Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Hyperimmune Globulins Sales Market Share in Value by Application (2020-2025)

Table 32. Global Hyperimmune Globulins Sales Market Share in Value by Application (2026-2031)

Table 33. Global Hyperimmune Globulins Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Hyperimmune Globulins Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Hyperimmune Globulins Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Hyperimmune Globulins Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Hyperimmune Globulins Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Hyperimmune Globulins Price by Application (2020-2025) & (USD/Unit)

Table 39. Global Hyperimmune Globulins Price by Application (2026-2031) & (USD/Unit)

Table 40. Global Hyperimmune Globulins Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Hyperimmune Globulins Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Hyperimmune Globulins Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Hyperimmune Globulins Sales Value by Region (2020-2025) & (%)

Table 44. Global Hyperimmune Globulins Sales Value by Region (2026-2031) & (%)

Table 45. Global Hyperimmune Globulins Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Hyperimmune Globulins Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Hyperimmune Globulins Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Hyperimmune Globulins Sales Volume by Region (2020-2025) & (%)

Table 49. Global Hyperimmune Globulins Sales Volume by Region (2026-2031) & (%)

Table 50. Global Hyperimmune Globulins Average Price by Region (2020-2025) & (USD/Unit)

Table 51. Global Hyperimmune Globulins Average Price by Region (2026-2031) & (USD/Unit)

Table 52. Key Countries/Regions Hyperimmune Globulins Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Hyperimmune Globulins Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Hyperimmune Globulins Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Hyperimmune Globulins Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Hyperimmune Globulins Sales Volume, (2026-2031) & (K Units)

Table 57. CSL Behring Company Information

Table 58. CSL Behring Introduction and Business Overview

Table 59. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 60. CSL Behring Hyperimmune Globulins Product Offerings

Table 61. CSL Behring Recent Development

Table 62. Grifols Company Information

Table 63. Grifols Introduction and Business Overview

Table 64. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 65. Grifols Hyperimmune Globulins Product Offerings

Table 66. Grifols Recent Development

Table 67. Biotest Company Information

Table 68. Biotest Introduction and Business Overview

Table 69. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 70. Biotest Hyperimmune Globulins Product Offerings

Table 71. Biotest Recent Development

Table 72. Kedrion Company Information

Table 73. Kedrion Introduction and Business Overview

Table 74. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 75. Kedrion Hyperimmune Globulins Product Offerings

Table 76. Kedrion Recent Development

Table 77. CBPO Company Information

Table 78. CBPO Introduction and Business Overview

Table 79. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. CBPO Hyperimmune Globulins Product Offerings

Table 81. CBPO Recent Development

Table 82. Emergent (Cangene) Company Information

Table 83. Emergent (Cangene) Introduction and Business Overview

Table 84. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 85. Emergent (Cangene) Hyperimmune Globulins Product Offerings

Table 86. Emergent (Cangene) Recent Development

Table 87. Kamada Company Information

Table 88. Kamada Introduction and Business Overview

Table 89. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 90. Kamada Hyperimmune Globulins Product Offerings

Table 91. Kamada Recent Development

Table 92. CNBG Company Information

Table 93. CNBG Introduction and Business Overview

Table 94. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 95. CNBG Hyperimmune Globulins Product Offerings

Table 96. CNBG Recent Development

Table 97. Hualan Bio Company Information

Table 98. Hualan Bio Introduction and Business Overview

Table 99. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 100. Hualan Bio Hyperimmune Globulins Product Offerings

Table 101. Hualan Bio Recent Development

Table 102. Shanghai RAAS Company Information

Table 103. Shanghai RAAS Introduction and Business Overview

Table 104. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 105. Shanghai RAAS Hyperimmune Globulins Product Offerings

Table 106. Shanghai RAAS Recent Development

Table 107. Sichuan Yuanda Shuyang Company Information

Table 108. Sichuan Yuanda Shuyang Introduction and Business Overview

Table 109. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 110. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Offerings

Table 111. Sichuan Yuanda Shuyang Recent Development

Table 112. ADMA Biologics Company Information

Table 113. ADMA Biologics Introduction and Business Overview

Table 114. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 115. ADMA Biologics Hyperimmune Globulins Product Offerings

Table 116. ADMA Biologics Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Hyperimmune Globulins Downstream Customers

Table 120. Hyperimmune Globulins Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Hyperimmune Globulins Product Picture

Figure 2. Global Hyperimmune Globulins Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Hyperimmune Globulins Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Hyperimmune Globulins Sales Volume (2020-2031) & (K Units)

Figure 5. Global Hyperimmune Globulins Sales Price (2020-2031) & (USD/Unit)

Figure 6. Hyperimmune Globulins Report Years Considered

Figure 7. Global Hyperimmune Globulins Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Hyperimmune Globulins Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hyperimmune Globulins Revenue in 2024

Figure 10. Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Hepatitis B Immunoglobulins Picture

Figure 12. Rabies Immunoglobulins Picture

Figure 13. Tetanus Immunoglobulins Picture

Figure 14. Rho(D) Immunoglobulins Picture

Figure 15. Herpes Zoster Immune Globulin Picture

Figure 16. Other Picture

Figure 17. Global Hyperimmune Globulins Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 18. Global Hyperimmune Globulins Sales Value Market Share by Type, 2024 & 2031

Figure 19. Global Hyperimmune Globulins Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 20. Global Hyperimmune Globulins Sales Volume Market Share by Type, 2024 & 2031

Figure 21. Global Hyperimmune Globulins Price by Type (2020-2031) & (USD/Unit)

Figure 22. Product Picture of Government Institutions

Figure 23. Product Picture of Private Sector

Figure 24. Product Picture of Other

Figure 25. Global Hyperimmune Globulins Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 26. Global Hyperimmune Globulins Sales Value Market Share by Application, 2024 & 2031

Figure 27. Global Hyperimmune Globulins Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 28. Global Hyperimmune Globulins Sales Volume Market Share by Application, 2024 & 2031

Figure 29. Global Hyperimmune Globulins Price by Application (2020-2031) & (USD/Unit)

Figure 30. North America Hyperimmune Globulins Sales Value (2020-2031) & (US$ Million)

Figure 31. North America Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

Figure 32. Europe Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

Figure 34. Asia Pacific Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Hyperimmune Globulins Sales Value by Region (%), 2024 VS 2031

Figure 36. South America Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 37. South America Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

Figure 38. Middle East & Africa Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 39. Middle East & Africa Hyperimmune Globulins Sales Value by Country (%), 2024 VS 2031

Figure 40. Key Countries/Regions Hyperimmune Globulins Sales Value (%), (2020-2031)

Figure 41. Key Countries/Regions Hyperimmune Globulins Sales Volume (%), (2020-2031)

Figure 42. United States Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 43. United States Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 44. United States Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 45. Europe Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 46. Europe Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 47. Europe Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 48. China Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 49. China Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 50. China Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 51. Japan Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 52. Japan Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 53. Japan Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 54. South Korea Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 55. South Korea Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 56. South Korea Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 57. Southeast Asia Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 58. Southeast Asia Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 59. Southeast Asia Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 60. India Hyperimmune Globulins Sales Value, (2020-2031) & (US$ Million)

Figure 61. India Hyperimmune Globulins Sales Value by Type (%), 2024 VS 2031

Figure 62. India Hyperimmune Globulins Sales Value by Application (%), 2024 VS 2031

Figure 63. Hyperimmune Globulins Industrial Chain

Figure 64. Hyperimmune Globulins Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Hyperimmune Globulins Market Research Report 2024

Global Hyperimmune Globulin Product Market Research Report 2024

Global Hyperimmune Globulin Injection Market Research Report 2024

Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intravenous Immunoglobulin IVIg Market Research Report 2025

Global Intravenous Immune Globulin Therapies Market Research Report 2024

IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Rabies Immune Globulin HRIG Market Research Report 2024

IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prophylactic Gamma Globulin Market Research Report 2024

Human Varicella Zoster Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Normal Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030

Animal derived Immune Globulin Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-13I9059

Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

FEATURED COMPANIES

Hyperimmune Globulins- Market Size

Hyperimmune Globulins- Market

Scope of Hyperimmune Globulins- Market Report

Chapter Outline

FAQ for this report

What is the Hyperimmune Globulins- Market size in 2031?

What is the market share of major companies in Hyperimmune Globulins- Market?

Who are the main players in the Hyperimmune Globulins- Market report?

What are the Application segmentation covered in the Hyperimmune Globulins- Market report?

What are the Type segmentation covered in the Hyperimmune Globulins- Market report?

FEATURED COMPANIES

RELATED REPORTS